Konrad Glund is a Co-Founder of Vivoryon Therapeutics NV, a clinical-stage biopharmaceutical company focused on small molecule-based medicines.
Konrad Glund is a Co-Founder of Vivoryon Therapeutics NV, a clinical-stage biopharmaceutical company focused on small molecule-based medicines for Alzheimer's disease. He previously served as CEO of Probiodrug, the company that evolved into Vivoryon Therapeutics. Glund is currently listed as an Advisor to Vivoryon Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library